Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics.

about

Pharmacogenomics of oral antiplatelet drugs.P450 Pharmacogenetics in Indigenous North American Populations.Pharmacogenetic landscape of clopidogrel in north Indians suggest distinct interpopulation differences in allele frequencies

P2860

Q38195628-C24A229D-52F8-4F71-8B52-0CDD25C9D12C Q47546933-1631825D-D8B7-492A-87AA-135E55BA90B9 Q57075981-E378426A-01AF-4D81-92B9-A9A9BF519B0F

P2860

Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics.

Item

http://www.wikidata.org/entity/Q39948342

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Implications of Inter-Individu ...... ith Focus on Pharmacogenetics.

@en

Implications of Inter-Individu ...... ith Focus on Pharmacogenetics.

@nl

type

Item

label

Implications of Inter-Individu ...... ith Focus on Pharmacogenetics.

@en

Implications of Inter-Individu ...... ith Focus on Pharmacogenetics.

@nl

prefLabel

Implications of Inter-Individu ...... ith Focus on Pharmacogenetics.

@en

Implications of Inter-Individu ...... ith Focus on Pharmacogenetics.

@nl

P1476

Implications of Inter-Individu ...... ith Focus on Pharmacogenetics.

@en

P2093

Arzu Gunes

http://www.w3.org/2001/XMLSchema#string

Marja-Liisa Dahl

http://www.w3.org/2001/XMLSchema#string

P2860

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction.

Pharmacogenomics--drug disposition, drug targets, and side effects.

P304

782-794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH3040782

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42539402

http://www.w3.org/2001/XMLSchema#string

P698

27713279

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

P932

4034010

http://www.w3.org/2001/XMLSchema#string

Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics.

about

P2860

P2860

Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932